Ark Therapeutics - US Patent For Kerraboot

Ark Therapeutics Group plc today announces the grant of its patent in the US, Patent Number 6982358, for Kerraboot(R), a novel woundcare device for the management of leg and foot ulcers. Kerraboot(R) has already been listed for marketing by the Food and Drug Administration in the US.

MORE ON THIS TOPIC